Moreover, the expression of matrix metalloproteinase-9 (MMP-9) protein, a key factor of bladder cancer invasiveness regulated by the PI3K/Akt signaling pathway34, decreased in presence of the miR-130 family inhibitors (Fig. 4d). The gene discussed is MMP9; the disease is urinary bladder carcinoma.